Epidemiology of care demands;Épidémiologie de la demande de soins

Presse Medicale

Volumn 31, Issue 4, 2002, Pages 167-175

  Landais, P ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN;

ARTICLE; DIALYSIS; FRANCE; GLOMERULONEPHRITIS; HEALTH CARE COST; HUMAN; KIDNEY FAILURE; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; RENOVASCULAR DISEASE; SURVIVAL; CHRONIC KIDNEY FAILURE; HEALTH SERVICE; INFORMATION SYSTEM; MORBIDITY; MORTALITY; RENAL REPLACEMENT THERAPY; STATISTICS;

FRANCE; HEALTH CARE COSTS; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INFORMATION SYSTEMS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MORBIDITY; MORTALITY; RENAL DIALYSIS;

EID: 2242455903     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (78)

1. L'insuffisance rénale terminale, un enjeu de santé publique
2. Trends in the epidemiology of end-stage renal disease over the last decade
3. L'insuffisance rénale terminale traitée en France-Epidémiologie et système d'information
4. Actes du colloque "Insuffisance rénale chronique et santé publique"
5. Indications de l'épuration extra-rénale dans l'insuffisance rénale chronique terminale
6. Report on management of renal failure in Europe, XXIV, 1993
7. Epidemiological data of treated end-stage renal failure in the European Union (EU) during the year 1995: Report of the European Renal Association Registry and the National Registries
8. Les maladies rénales ischémiques sont devenues les causes les plus fréquentes d'insuffisance rénale terminale chez les sujets âgés
9. Traitement de l'insuffisance rénale terminale en Languedoc-Roussillon en 1994
10. Epidemiology of end-stage renal disease in the Ile-de-France area: A prospective study in 1998
11. Intérêt d'un registre de l'insuffisance rénale terminale. Expérience de la région Champagne-Ardenne
12. Epidemiology of end-stage renal disease in Réunion Island (results from the registry of the Indian Ocean Society of Nelphrology)
13. Chronic renal failure: Factors influencing nephrology referral
14. Incidence of advanced chronic renal failure and the need for end stage renal replacement therapy
15. Geographical variation in the referral of patients with chronic end stage renal failure for renal replacement therapy
16. Acess to kidney transplantation: Has the United States climinated income and racioal differences?
17. Socio economic status and end-stage renal disease in the United States
18. Racial differences in access to kidney transplantation
19. The impact of comorbid an sociodemographic factors on access to renal transplantation
20. Barriers to cadaveric renal transplantation among blacks, women and the poor
21. The effect of patients' preferences on racial differences in access to renal transplantation
22. What determines geographical varaitions in rates of acceptance onto replacement therapy in England?
23. Treatment of end stage renal disease in central and east'em Europe: Overview of current status and future needs
24. Comparability of the different registries on renal replacement therapy
25. Why has the gross mortality of dialysis patients increased in Japan?
26. Insuffisance rénale terminale dans le sud de la Réunion: Épidémiologie, survie en dialyse
27. IRC 2000: Le livre blanc de la néphrologie
28. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus
29. Comorbidty: The major challenge for survival and quality of life in end-stage renal failure
30. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
31. Risk adjustment in claims-based research: The search for efficient approaches
32. Comorbidities, complications, and coding bias - Does the number of diagnosis codes matter in predicting in-hospital mortality?
33. Medical expenditures for disability and disabling comorbidity
34. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives
35. Adapting a clinical comorbidity index for use with ICD 9-CM administrative data: A response
36. The importance of coexisting disease in the occurrence of post operative complications and one-year recovery in patients undergoing total hip replacement - Comorbidity and outcomes after hip replacement
37. Searching for an improved clinical comorbidity index for use with ICD-9-CM administrative data
38. Influence of coexisting disease on survival on renal replacement therapy
39. Comorbidities and their impact on outcome in patients with end-stage renal disease
40. Is there a rationale for rationing chronic dialysis? A hospital based cohort study of factors affecting survival and morbidity
41. Statistical methods for comparing mortality among ESRD patients: Examples of regional/international variations
42. Validation of comorbid conditions on the End-Stage Renal Disease Medical evidence report: The CHOICE study
43. An improved understanding of the causes of end-stage renal disease
44. Distribution of primary renal disease leading to end-stage renal failure in the United States, Europe and Australia/New zealand: Results from an international comparative study
45. Hypertension as cause of end-stage renal disease: Lessons from international registries
46. Diabetic nephropathy in type II diabetes
47. Blood pressure and end-stage renal disease in men
48. Huge progression of diabetes prevalence and incidence among dialysed patients in mainland France and overseas French territories. A second national survey six years apart (UREMIDIAB 2 study)
49. Nephropathy in patients with type 2 diabetus mellitus
50. The rising tide of end-stage renal failure from diabetic nephropathy type 2; an epidemiological analysis
51. End-stage renal failure in type 2 diabetes - A medical catastrophe of worldwide dimensions
52. Risk of end-stage renal disease in diabetes mellitus: A prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial
53. Diabetes mellitus in Tassin, France: Remarkable transformation in incidence and outcome of ESRD in diabetes
54. Continuous ambulatory peritoneal dialysis and hemodialysis: Comparison of patient mortality with adjustment for comorbid conditions
55. Dialysis therapy
56. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here?
57. Nutrition in end-stage renal disease
58. Nutritional status of haemodialysis patients: A French national cooperative study
59. Influence of nutritional factors and hemodialysis adequacy on the survival of 1,610 French patients
60. End-stage renal disease therapy: An American success story
61. Trends in mortality rates on hemodialysis in Canada, 1981-1997
62. Trends in mortality rates on peritoneal dialysis: Canada, 1981-1997
63. The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study
64. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis
65. Mortality in ESRD: A reassessment of differences between patients treated with hemodialysis and peritoneal dialysis
66. Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates
67. Statistical methods for comparing mortality among ESRD patients: Examples of regional/international variations
68. Update on organ donation and retrieval in Spain
69. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant
70. International figures on organ donation and transplantation activities 1998
71. Report on dialysis and transplantation
72. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant
73. Quality of life issues for end-stage renal disease patients
74. A survival advantage for renal transplantation